Boardroom Alpha
8-K primary document
PPHC · Current Report (Form 8-K) · Filed February 2, 2026

Public Policy Holding Company Inc8-K exhibit

exhibit103-closing8xk.htm
Document
Exhibit 10.3
Execution Version
January 28, 2026
Mr. Benjamin Ginsberg
c/o Public Policy Holding Company, Inc.
800 North Capitol St., NW, Suite 800
Washington, DC, 20002
Re:Amendment to NED Appointment Letter
Dear Ben:
In connection with the anticipated listing of the stock of Public Policy Holding Company, Inc. (“PPHC”) on The Nasdaq Global Market (the “Listing”), your letter agreement with PPHC, dated December 13, 2021 (the “NED Appointment Letter”) is hereby amended as follows, such amendment to be conditional upon, and effective immediately prior to, the Listing (the “Effective Time”):
1.Section 2 – at the Effective Time, your current appointment as a Class II Director of the Board of Directors of PPHC (the “Board”) shall continue, and your current appointment as a member of the Audit Committee of the Board shall continue, but you shall no longer be a member of the Compensation Committee (formerly, the Remuneration Committee) of the Board. In addition, you have been appointed to be a member of the Board’s new Nominating and Corporate Governance Committee, to be effective at the Effective Time.
2.Section 5 – from and after the Effective Time, your fee as a director on the Board shall be increased from US$80,000 to US$180,000 per annum before tax which will subject to annual review by the Board. Such payment will consist of US$80,000 cash (to be paid quarterly in arrears) and US$100,000 in Restricted Stock Unit awards (vesting on the first anniversary date of the grant date) under PPHC’s Amended and Restated 2021 Omnibus Incentive Plan (as amended, restated and in effect from time to time).
3.Section 7 – the provisions of Section 7 (Insurance and Indemnity) of the NED Appointment Letter shall be subject to the terms and conditions of that certain Indemnification Agreement, dated January 28, 2026, by and between you and PPHC.
Except as amended hereby, the NED Appointment Letter shall continue in full force and effect in accordance with its terms. Nothing herein amends or supersedes anything in the Certificate of Incorporation of PPHC, the Bylaws of PPHC, the Board committee charters of PPHC, and all other PPHC policies applicable to the Board and directors, in each case, as amended, restated and in effect from time to time.
If you agree, please acknowledge by signing below.
Sincerely,
Public Policy Holding Company, Inc.
By:/s/ Stewart Hall
Name: Stewart Hall
Title: CEO
Acknowledged and Agreed:
/s/ Benjamin Ginsberg
Benjamin Ginsberg

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer